Results 91 to 100 of about 40,013 (196)

Presumed TP53 mosaicism: variants detected using a NGS hereditary cancer multigene panel [PDF]

, 2019
Aims/Context: NGS multigene panels are routinely used to identify germline pathogenic variants in cancer susceptibility genes. In addition, NGS allows the identification of low-level mosaicism events that may not be detectable by conventional Sanger ...
Gonçalves, João, Rodrigues, Márcia, Rodrigues, Pedro, Silva, Catarina, Theisen, Patrícia, Vieira, Luís   +5 more
core  

MSH2 Negative [PDF]

, 2020
openaire   +1 more source

Significance of MSH2 promoter methylation in endometrial cancer with MSH2 deficiency

Annals of Oncology, 2017
J. Haraga, T. Nagasaka, K. Nakamura, T. Haruma, T. Nishida, A. Nyuya, K. Yasui, T. Fujiwara, A. Goel, H. Masuyama   +9 more
openaire   +1 more source

MSH2 Gene [PDF]

, 2020
openaire   +1 more source

MSH2 NP_000242.1:p.A636P [PDF]

, 2020
openaire   +1 more source

MSH2 Protein Variant [PDF]

, 2020
openaire   +1 more source

MSH2 wt Allele [PDF]

, 2020
openaire   +1 more source

Clinical Discovery and Molecular Analysis of Two Novel MSH2 Gene Mutations (p.Ala771Gly and p.Val797Gly) in Saudi Colorectal Cancer Patients: Potential Implications for Tumorigenesis. [PDF]

Health Sci Rep
Rasool M, Haque A, Alharthi M, Ali T, Karim S, Mira LS, Al-Abbasi F, Aljiffry M, Ghunaim M, Sibiany A, Pushparaj PN.   +10 more
europepmc   +1 more source

MSH2 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer. [PDF]

Clin Transl Gastroenterol
Zhang ZR, Wang Y, Yan WW, Li HR, Cheng ZW, Han T, Zhang C, Wang XM.   +7 more
europepmc   +1 more source